NY Attorney General Demands Hospital Resume Trans Youth Gender-Affirming Care
New York Attorney General Letitia James has issued a formal order compelling NYU Langone, one of Manhattan's largest hospital systems, to immediately resume providing gender-affirming healthcare treatments for transgender patients under the age of 19. This directive comes just weeks after the hospital announced it would phase out such services, citing federal funding threats and staffing changes.
Legal Action Over Healthcare Access
In a strongly worded letter dated February 25, the Attorney General's office asserted that NYU Langone's decision to shutter its Transgender Youth Health Program violated New York State's comprehensive anti-discrimination statutes. The correspondence specifically highlighted how the hospital's actions were "jeopardizing access to medically necessary healthcare for some of the most vulnerable New Yorkers."
The letter, signed by Darsana Srinivasan, chief of the attorney general's healthcare bureau, warned of "severe, negative health outcomes" resulting from the sudden discontinuation of these critical treatments. It emphasized that the hospital's obligations under New York law remained unchanged despite recent federal regulatory proposals.
Hospital's Controversial Decision
NYU Langone announced last month it would gradually eliminate certain gender-affirming treatments for minors, including hormone therapies and puberty blockers. The hospital attributed this policy shift to the "current regulatory environment" and the recent departure of a key medical director. At the time, hospital officials stated they were "committed to helping patients in our care manage this change."
This decision followed a proposal from the U.S. Department of Health and Human Services to potentially cut federal Medicaid and Medicare funding to hospitals providing gender-affirming care to minors. However, the attorney general's letter clarified these proposals did not alter existing federal law or medical institutions' responsibilities under New York statutes.
National Context and Medical Community Response
The situation at NYU Langone reflects a broader national trend, with several hospitals across the United States pausing transgender youth treatments following an executive order from President Donald Trump. That order threatened to withhold research and education grants from hospitals providing what it termed the "chemical and surgical mutilation of children."
Medical associations and transgender advocacy groups have universally condemned such language and policy changes. Dr. Scott Leibowitz, a psychiatrist and board member for the World Professional Association for Transgender Health, warned that "this sets a very dangerous precedent for all areas of health care, if the government can cherry-pick one area of medicine to use to withhold necessary funding from entire groups of people."
Compliance Deadline and Potential Consequences
Attorney General James has given NYU Langone until March 11 to demonstrate compliance by resuming gender-affirming care services. The letter explicitly promised "further action" if the hospital fails to meet this deadline, though a spokesperson for the attorney general's office declined to specify what measures might follow.
A spokesperson for NYU Langone has declined to comment on the attorney general's letter. The hospital now faces a critical decision between potential legal consequences from state authorities and continued pressure from federal funding threats, all while navigating complex medical, ethical, and regulatory landscapes affecting vulnerable patient populations.
